Medline Inc. Q2 2026 Earnings Recap

Medline’s shares dropped 17.9% following an outlook moderation driven by operational headwinds including the Tracy warehouse fire, quality remediation costs, and softness in the retail segment, which overshadowed strong sales growth and new customer wins.

Key Takeaways

• Reported 12% top-line growth in Q2, with Medline Brand up 7% and Supply Chain Solutions rising 16%.
• Adjusted EBITDA increased 13% to $1.1 billion but was pressured by higher costs, operational expenses, and net tariff impacts.
• Headwinds such as the Tracy distribution center fire, Middle East conflict, growth investments, and quality remediation efforts led to a cautious full-year EBITDA outlook.
• Customer signings exceeded $650 million, pacing ahead toward the $1 billion annual goal.
• Retail business showed softness, contributing to the overall cautious outlook and margin pressures.